Vaccine to Save Against Deadly Addiction

    Researchers approve of a vaccine against cocaine noting that it is  effective in nearly 40 % of users of the drug.

Photo: Vaccine to Save Against Deadly Addiction

Vaccine to Save Against Deadly Addiction

  In a randomized, placebo-controlled study, volunteers who reached a high level of antibodies after vaccination used less cocaine than those whose response was lower, according to Dr. Thomas Kosten of Baylor College of Medicine in Houston and colleagues.

   But as the effect of the vaccine wore off, antibody levels fell and many volunteers returned to abusing the drug, Kosten and colleagues said in the October issue of Archives of General Psychiatry.

  Kosten said that the researchers did not expect to cure the addicts in six months.

  But he said that other studies have shown that a booster shot every two months can keep antibody levels high enough to block the euphoric effects of cocaine.

  That, he noted, might allow enough time off the drug to let psychosocial forms of treatment have an effect.

   Kosten and colleagues tested a vaccine designed to tie up cocaine molecules in the blood where they can be degraded. That delay ensures that less of the drug reaches the brain and the euphoric effect is muted or nonexistent.

  Indeed, Kosten said, some vaccinated volunteers said they tried larger than normal doses of cocaine during the study and reported no effect.

   Cocaine-using volunteers, all enrolled in a methadone program for opiate abuse, either received five shots of vaccine or a placebo over a 12-week period. They were observed for an additional 12 weeks.

   All volunteers reduced cocaine use during the study, but those with high levels of antibody -- indicating they had received the vaccine -- had a significantly greater decrease during weeks nine through 16 of the study.

   Adverse effects of the vaccine were limited to redness and soreness at the injection site.

   A major hurdle, Kosten said, is to find a pharmaceutical company that's willing to develop a cocaine vaccine.

   In the meantime, there are no approved pharmacologic approaches to cocaine addiction, he said, and even a treatment that would work for 38 % of addicts would be "damn good."

ABC News contributed to the report.